IsoRay (ISR) Announces Presentation of Positive Cesium-131 Brachytherapy Data at SNO Conference

IsoRay Inc. announced David G. Brachman, MD, FACRO, Director of Radiation Oncology, Barrow Neurological Institute, and Clinical Professor of Radiation Oncology, University of Arizona College of Medicine-Phoenix, presented the findings of a prospective trial entitled: “Prospective trial of surgery and permanent intraoperative brachytherapy (S+BT) using a modular, biocompatible radiation implant for recurrent aggressive meningiomas,” at the Society of Neuro-Oncology Conference on Meningioma, Toronto, Canada. Read more here.